Galectin Therapeutics (GALT) EBITDA (2010 - 2021)
Galectin Therapeutics (GALT) posted EBITDA of -$8.18 million for Q2 2021, compared with -$6.09 million a year earlier.
Powered by 
Analysis
Galectin Therapeutics (GALT) EBITDA (2010 - 2021) Analysis & Trends
For the trailing twelve months through Jun 30, 2021, EBITDA at Galectin Therapeutics was -$28.23 million; for FY2020, it was -$23.41 million.
- In prior years, Galectin Therapeutics' EBITDA was -$13.4 million in FY2019, -$13.6 million in FY2018, -$16.25 million in FY2017 and -$21.47 million in FY2016.
- The Q2 2021 figure stands as the lowest quarterly EBITDA in data going back to Q3 2010.
- According to Business Quant data, EBITDA for the three prior quarters was -$6.31 million (Q1 2021), -$7.82 million (Q4 2020) and -$5.92 million (Q3 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Galectin Therapeutics | 260.61 Mn | 260.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -8.18 Mn |
| Mar 31, 2021 | -6.31 Mn |
| Dec 31, 2020 | -7.82 Mn |
| Sep 30, 2020 | -5.92 Mn |
| Jun 30, 2020 | -6.09 Mn |
| Mar 31, 2020 | -3.58 Mn |
| Dec 31, 2019 | -5.18 Mn |
| Sep 30, 2019 | -2.86 Mn |
| Jun 30, 2019 | -3.01 Mn |
| Mar 31, 2019 | -2.36 Mn |
| Sep 30, 2018 | -2.68 Mn |
| Jun 30, 2018 | -3.76 Mn |
| Mar 31, 2018 | -4.18 Mn |
| Dec 31, 2017 | -2.37 Mn |
| Sep 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.51 Mn |
| Mar 31, 2017 | -4.95 Mn |
| Dec 31, 2016 | -4.60 Mn |
| Sep 30, 2016 | -4.54 Mn |
| Jun 30, 2016 | -5.53 Mn |
API Access
Galectin Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();